⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2063077 | 0.81 | — | — | |
| SCHEMBL526332 | 0.78 | — | — | |
| SCHEMBL25179568 | 0.77 | CA1 (0.35) | — | |
| SCHEMBL455193 | 0.76 | — | — | |
| SCHEMBL866509 | 0.76 | — | — | |
| SCHEMBL8520637 | 0.76 | TSHR (0.42) | — | |
| SCHEMBL4786114 | 0.76 | — | — | |
| SCHEMBL232854 | 0.76 | — | — | |
| SCHEMBL29956913 | 0.76 | — | — | |
| SCHEMBL17667385 | 0.74 | TSHR (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120027677-A1 | Prion-specific peptoid reagents | NOVARTIS AG | 2012-02-02 | — | — | US | claimed |
| EP-2383281-A2 | Prion-specific peptoid reagents | Novartis AG (CH) | 2011-11-02 | — | — | EP | claimed |
| US-6756199-B1 | USED FOR THE SYNTHESIS OF BOTH PREDEFINED AND RANDOM SEQUENCE PEPTIDE NUCLEIC ACID OLIGOMERS | ISIS PHARMACEUTICALS, INC. | 2004-06-29 | — | — | US | claimed |
| EP-1369037-B2 | Synergistic preparations based on mixtures of glycerol ether with aromatic alcohol for controlling mycobacteria | SCHUELKE & MAYR GMBH (DE) | 2024-07-17 | — | — | EP | disclosed |
| EP-3193941-B1 | PRODRUGS COMPRISING AN AMINOALKYL GLYCINE LINKER | ASCENDIS PHARMA AS (DK) | 2024-05-22 | — | — | EP | disclosed |
| EP-3565573-B1 | PAC1 RECEPTOR AGONISTS (MAXCAPS) AND USES THEREOF | UNIV CALIFORNIA (US) | 2023-08-23 | — | — | EP | disclosed |
| US-11707431-B2 | Dental strips for the delivery of specifically targeted antimicrobial peptides | C3 JIAN, LLC (US) | 2023-07-25 | — | — | US | disclosed |
| US-20230146954-A1 | MICELLAR DISINFECTANTS | DENT4YOU AG (CH) | 2023-05-11 | — | — | US | disclosed |
| US-11633341-B2 | Dental varnishes that release specifically targeted antimicrobial peptides and/or fluoride | C3 JIAN, LLC (US) | 2023-04-25 | — | — | US | disclosed |
| US-11555055-B2 | Peptide inhibitors of insulin-degrading enzyme | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-01-17 | — | — | US | disclosed |
| EP-4110055-A1 | MICELLAR DISINFECTANTS | Dent4You Ag (CH) | 2023-01-04 | — | — | EP | disclosed |
| EP-1369037-A1 | Synergistic preparations based on mixtures of glycerol ether with aromatic alcohol for controlling mycobacteria | Air Liquide Santé (International) (FR) | 2003-12-10 | — | — | EP | disclosed |
| US-6608026-B1 | Contacting pathogenic cells with AV peptoid which comprises amino acid sequence Ala-Val-Pro, is fewer than 20 residues in length, has molecular weight less than 1000, and interacts with Inhibitor of Apoptosis protein, to enhance apoptosis | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2003-08-19 | — | — | US | disclosed |
| WO-2002016402-A2 | APOPTOTIC COMPOUNDS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2002-02-28 | — | — | WO | disclosed |
| EP-0535155-B1 | LIBRARIES OF MODIFIED PEPTIDES WITH PROTEASE RESISTANCE | CHIRON CORP (US) | 2002-01-30 | — | — | EP | disclosed |
| US-6075121-A | HETEROPOLYMERIC PEPTOID COMPOUND CONSISTING OF 2 TO 50 N-SUBSTITUTED GLYCINES HAVING DIFFERENT ALPHA-AMINO R GROUPS; CAPABLE OF NON-NATURAL CONFIGURATIONS FOR DRUG DESIGN | CHIRON CORPORATION (US) | 2000-06-13 | — | — | US | disclosed |
| US-5965695-A | PEPTOIDS COMPRISED OF 2-50 MONOMER UNITS INCLUDING AT LEAST 2 N-SUBSTITUTED GLYCINE RESIDUES; THE PEPTOIDS ARE CONJUGATED TO A DRUG SUCH AS AZT OR TRIMETHOPRIM, FOR INCREASED BINDING AFFINITY TO A PARTICULAR BIOLOGICAL RECEPTOR | CHIRON CORPORATION (US) | 1999-10-12 | — | — | US | disclosed |
| US-5811387-A | ENZYME RESISTANT OLIGO- OR POLY-PEPTOID WHICH MAY SELECTIVELY BIND TO POLYPEPTIDE OR EFFECTOR MOLECULE; MIMETICS, PEPTOID LIBRARIES | CHIRON CORPORATION (US) | 1998-09-22 | — | — | US | disclosed |
| EP-0535155-A4 | LIBRARIES OF MODIFIED PEPTIDES WITH PROTEASE RESISTANCE | BARTLETT PAUL A (US) | 1994-08-17 | — | — | EP | disclosed |
| EP-0535155-A1 | LIBRARIES OF MODIFIED PEPTIDES WITH PROTEASE RESISTANCE | BARTLETT, Paul A. (US) | 1993-04-07 | — | — | EP | disclosed |